Nakamuraya Co., Ltd. operates in the Candy & other confectionery products sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Nakamuraya Co., Ltd. with three other
bakery and confectionary companies in Asia:
GlaxoSmithKline Consumer Healthcare Limited
sales of 43.09 billion Indian Rupees [US$645.88 million]
of which 100%
Imuraya Group Company Limited
(38.64 billion Japanese Yen [US$372.15 million]
of which 88%
was Distribution Business), and
Ismail Industries Limited
based in Pakistan
(17.01 billion Pakistan Rupees [US$162.43 million]
Nakamuraya Co., Ltd. reported sales of ¥41.37 billion (US$398.38 million)
March of 2016.
decrease of 0.5%
versus 2015, when the company's sales were ¥41.59 billion.
The sales level in 2016 was fairly close to the level five years ago: in 2011, Nakamuraya Co., Ltd. had sales
of ¥41.02 billion.
Contributing to the drop in overall sales was the 2.4% decline
in Food Business, from ¥7.12 billion to ¥6.95 billion.
There were also decreases in sales in
Confectionery Business (down 1.8% to ¥29.13 billion)
However, these declines were partially offset by the increase in sales of
Restaurant Business (up 6.3% to ¥3.12 billion)
Real Estate Leasing Business (up 22.2% to ¥1.30 billion)
Other Businesses (up 6.2% to ¥881.81 million)